BioSpace News Archive

Proceeds from the €10m equity investment from Autobio will be used by Mobidiag to continue growing its product portfolio, accelerate the development of further assays for the Novodiag® system and enhance its manufacturing capabilities, as well as continuing to facilitate Mobidiag’s commercial expansion.

New company will provide expertise and services to organizations transitioning from costly in-patient care to cost-efficient, ambulatory care and digital engagement

Diaceutics announces results of patient research as it sponsors UICC’s World Cancer Day

In addition to his CEO duties he will remain Vice Chairman of the Board of Directors.

Infinity Pharmaceuticals, Inc. (NASDAQ: INFI) announced today that Adelene Perkins, Infinity Pharmaceutical’s Chief Executive Officer, will present at the BIO CEO & Investor Conference on Monday, February 11, 2019, at 10:00 a.m. EST at The New York Marriott Marquis in New York, NY

Collaboration to Support Clinical Study of Bryostatin-1 in Leukemia and B-cell Lymphoma

KJT Group is pleased to announce Lynn Clement has been promoted to Chief Research Officer.

RXTransparent is proud to announce that RxTrail’s Drug Supply Chain Security Act (DSCSA) customers will be migrating to the RXTransparent Compliance platform.

Tenax Therapeutics, Inc. (Nasdaq: TENX), a specialty pharmaceutical company focused on identifying and developing drugs that address diseases with high unmet medical need, today announced that management is scheduled to present and conduct one-on-one meetings at the 2019 BIO CEO & Investor Conference to be held in New York, NY on February 11th and 12th

Partnership melds firms’ commitment to innovation in dermatology and patient-centric approach